Short answer: GLP-1 medications, such as semaglutide (marketed as Ozempic or Wegovy) and tirzepatide (marketed as Mounjaro), can genuinely help some women navigating menopause-related weight and visceral fat changes, particularly where lifestyle measures alone haven’t been enough. They’re not appropriate for everyone, they carry real risks if used without close supervision, and suitability comes down to your individual health history, not menopause status alone.
Everyone seems to have an opinion on GLP-1 medications. Almost nobody is giving you the version that actually applies to your body, your hormones, and your history. Let’s fix that.
Why This Question Has Exploded
Prescription data shows women have been prescribed GLP-1 medications at notably higher rates than men in recent years, with the steepest interest concentrated in women approaching or in menopause. It makes sense. Midlife weight gain is common, often resistant to strategies that used to work, and exhausting to keep fighting. What’s missing from most of what’s written about it is the individualised, hormone-literate part, and the safety detail that actually matters.
What the Research Actually Shows
Emerging research specifically in menopausal and postmenopausal women shows GLP-1 receptor agonists are associated with meaningful weight loss and reductions in visceral fat, the metabolically active fat around your organs that drives much of the cardiovascular and metabolic risk in midlife. Some studies suggest a possible improvement in hot flashes and cardiovascular markers too, though researchers are upfront that more menopause-specific evidence is still needed. Much of the existing data comes from broader obesity and diabetes populations rather than menopausal women directly.
There’s also growing interest in how GLP-1 medications and hormone therapy might work together, with some early evidence suggesting a combined approach may offer more than either alone for certain women.
Who Shouldn’t Use GLP-1 Medications
This is the part that tends to get skipped in the online conversation entirely. GLP-1 medications aren’t right for everyone, and a proper assessment needs to rule out several things before a prescription is appropriate, including:
- A personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2
- A history of pancreatitis
- Significant gastrointestinal disease affecting how the stomach empties, such as gastroparesis
- Pregnancy, breastfeeding, or actively trying to conceive
- Known hypersensitivity to the medication class
- Gallbladder disease, which needs individual consideration
- For women with diabetes, diabetic eye disease, since rapid improvements in blood sugar control can temporarily worsen it
This isn’t an exhaustive list, and it’s exactly why this decision needs a proper medical assessment rather than a script filled based on a five-minute online questionnaire.
The Part Almost Nobody Explains Properly: Why Supervision Matters
GLP-1 medications work by suppressing appetite significantly, and that’s exactly where another risk lives. If appetite drops sharply and protein intake drops along with it, you can lose muscle mass at the same time as fat, sometimes faster than you’d lose it through ageing alone. In midlife, when muscle is already declining and is central to metabolic health, that’s a genuinely poor trade-off.
Used well, a GLP-1 medication sits inside a bigger plan: adequate protein intake even when appetite is low, a deliberate strength training routine to protect the muscle you have, regular monitoring, and a clear strategy for what happens if or when you come off it. Used without that scaffolding, someone can end up lighter on the scale and worse off in terms of the muscle and metabolic health that actually matter for the long run.
Retatrutide, “Reta,” and Why Unapproved Medications Are a Genuine Risk
You may have come across retatrutide, sometimes called “Reta” online, a newer triple-receptor medication generating a lot of interest for its trial results. It’s worth being very clear about where things stand: retatrutide is still in Phase 3 clinical trials and is not approved by the TGA or any medicines regulator anywhere in the world. It isn’t legally available for therapeutic use in Australia, whatever a website or supplier might imply.
Because of that gap between demand and legal supply, some people are sourcing it and similar unapproved products through offshore suppliers or so-called research chemical channels, often labelled “not for human use” to sidestep regulation. There’s no quality control, no verified dosing, and no oversight of what’s actually in the vial. This isn’t a hypothetical concern. Australian health authorities have already linked a cluster of serious liver injury cases to unapproved retatrutide sourced through unverified channels. If a medication isn’t TGA-approved and isn’t coming through a legitimate prescription and pharmacy pathway, the risk isn’t just legal, it’s a genuine safety unknown.
If you’re curious about where the research is heading, that’s a great conversation to have with your doctor. It’s not a reason to source an unregulated product yourself.
The Judgement Women Face for Using Them, and Why It’s Misplaced
There’s a particular kind of shame attached to GLP-1 medications that doesn’t exist to the same degree with other treatments. Women who use them are called lazy, told they’ve taken the easy way out, or made to feel they should have “just tried harder” first. I want to address that directly, because it’s doing real damage.
Weight regulation in midlife has genuine, well-documented biological drivers: declining oestrogen, accelerating muscle loss, changing insulin sensitivity, and a metabolism that behaves differently than it did a decade earlier. Nobody would suggest a person with high blood pressure is cheating by taking medication instead of relying on diet and exercise alone, or that someone with an underactive thyroid should refuse thyroid hormone replacement out of principle. Using an evidence-based medical treatment for a condition with a real physiological basis isn’t a shortcut. It’s medicine.
That doesn’t mean every woman needs or should want a GLP-1 medication, and it doesn’t erase the genuine reasons to be thoughtful about who’s a good candidate. But the decision belongs to you and your doctor, based on your health, not on judgement from people who haven’t lived in a body going through this transition.
Who Tends to Be a Reasonable Candidate
This is always an individual clinical decision, but broadly, I’d consider approved GLP-1 medications for women who:
- Have made sustained changes to nutrition, strength training, sleep, and stress without adequate results
- Have a genuine clinical indication, such as obesity or weight-related health risk
- Don’t have contraindications specific to GLP-1 medications
- Understand this is a long-term consideration, not a short course. Most benefits only hold with continued use or a carefully managed transition off, alongside ongoing muscle and nutrition support
Who Might Look at Other Options First
- Women whose main complaints are hot flashes, mood, sleep, or vaginal symptoms, where hormone therapy may address the root cause more directly
- Women who haven’t yet trialled a structured strength-training and nutrition approach, which remains foundational whatever else is added
- Anyone considering sourcing medication through unregulated, unsupervised channels, for the reasons above
The Conversation Worth Having
Rather than “should I go on a GLP-1,” a more useful question is: given everything going on for me hormonally, what’s actually driving my weight, and what’s the right order of operations? Sometimes that’s hormone therapy first. Sometimes it’s lifestyle foundations plus a closely supervised, TGA-approved GLP-1 medication running in parallel. Sometimes it’s neither yet. This is exactly the kind of layered decision our Rediscover You program is built around, treating hormones, muscle, nutrition, and medication as one coordinated, properly supervised plan.
Frequently Asked Questions
Can I take a GLP-1 medication and HRT at the same time?
For many women, yes. The two aren’t mutually exclusive, and some evidence suggests they may work well together, assessed individually.
Do GLP-1 medications treat menopause symptoms directly?
No. Their primary role is appetite and weight regulation, though some research points to possible secondary benefits.
Is retatrutide available in Australia?
No. As of 2026, it remains in Phase 3 trials and isn’t approved by the TGA or any regulator worldwide. It isn’t legally available for therapeutic use here.
Are compounded versions of approved GLP-1 medications safe?
Compounded GLP-1 medications carry additional considerations around quality control and monitoring. This is worth discussing directly with your prescribing doctor rather than sourcing independently.
Will I regain weight if I stop?
For many people, some regain is common after stopping, which is why these medications are generally approached as a longer-term strategy alongside sustainable habits, including ongoing strength training.
If you’re weighing this up, bring the whole picture to the conversation, not just the number on the scale.
| WHERE TO START: Weight Management Consultation – a proper assessment of whether a GLP-1 medication suits your history, and what should run alongside it. 16-Week Rediscover You Menopause Program – hormones, muscle, nutrition and medication managed as one supervised plan. Both available at Forresters Beach and The Junction. No GP referral needed. |
This article is general information and doesn’t replace individualised medical advice.